14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close May 26, 2026
IPOD vs ABL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of May 26, 2026, Abacus Global Management, Inc. (ABL) is the stronger overall head-to-head candidate over IPOD (IPOD) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IPOD carries a Unified Composite Score of 58.0/100 (HOLD) at $10.42 (N/M Forward P/E, 0.0% operating margin), whereas ABL carries 61.3/100 (BUY) at $8.47 (8.6x Forward P/E, 35.6% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IPOD vs ABL. Trailing 12-month operating profitability (IPOD 0.0% vs ABL 35.6%) and valuation multiples (IPOD N/M vs ABL 8.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Shell Companies value chain with $210.0M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
ABL Moat ProfileHigh-Margin Pricing Power Moat
Insurance - Life Operator
Competes within the Insurance - Life value chain with $830.9M market capitalization and 35.6% operating margin.
OpEx & R&D Reinvestment51.9% of Rev ($45M)
90D Engineering Disclosures0 Published
Investor FAQ IPOD vs ABL Key Questions & Quantitative Answers
As of May 26, 2026, Abacus Global Management, Inc. (ABL) is the stronger overall head-to-head candidate over IPOD (IPOD) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IPOD carries a Unified Composite Score of 58.0/100 (HOLD) at $10.42 (N/M Forward P/E, 0.0% operating margin), whereas ABL carries 61.3/100 (BUY) at $8.47 (8.6x Forward P/E, 35.6% operating margin). Technically, IPOD sits in a Neutral phase (RSI N/A, UNCLASSIFIED options structure) and ABL sits in a Markup phase (RSI 67.8, UNCLASSIFIED options structure).
ABL leads the Growth & Scale pillar: IPOD posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with ABL at +123.7% YoY revenue growth and N/A YoY earnings growth on $87M TTM revenue (87.5% gross margin, 35.6% operating margin). On trailing 12-month operating scale, IPOD generates N/A in USD-normalized revenue versus $87M for ABL. In operating R&D and SG&A reinvestment, IPOD deploys N/A (0 90-day corporate R&D disclosures) versus 51.9% of Rev ($45M) (0 disclosures) for ABL.
ABL screens cheaper on headline valuation multiples. IPOD trades at N/M Forward P/E, 39.9x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ABL trades at 8.6x Forward P/E, N/M Trailing P/E, N/M PEG, and 9.6x EV/Revenue (36.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IPOD (0.0% ROE) versus ABL (3.2% ROE) capital efficiency.
In options market volatility and institutional positioning, IPOD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.00β · 2% Vol realized risk). By comparison, ABL carries 52.0% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.19β · 48% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of May 26, 2026. For educational research only; not investment advice.